alpe adria association of cardiology

V I 

18 th International Meeting of the 

ALPE ADRIA 

ASSOCIATION OF CARDIOLOGY 

E N 

N A 

“New Developments in Cardiology” 

Final Program 

Vienna, September 16-18, 2010 

Old General Hospital - Campus 

Vienna, Austria

Topics 

Heart Failure 

New Devices 

Atrial Fibrillation 

Diabetes and the Heart 

Antithrombotic Therapy 

Risk Factor Management 

Interventional Cardiology 

Acute Coronary Syndromes 

Networks for Myocardial Infarction 

Conservative and Invasive Rhythmology 

Transcutaneous Valve Repair and Replacement 

1

Preface 

Welcome to the 18 th International Meeting of the ALPE ADRIA CARDIOLOGY ASSO- 

CIATION, which will take place for the second time in Vienna, Austria. The topics chosen 

for this meeting are across cardiology but concentrate on new developments in the 

past year and are, therefore, of high importance and interest. This is also expressed in 

the subtitle of the meeting "New Developments in Cardiology". 

It is the intention of the organizers to make this meeting a special event not only for experienced 

cardiologists but also and especially for young researchers from the ALPE 

ADRIA nations, clinical and basic researchers alike. 

All presenters of posters and all speakers and/or chairs will have free access to the meeting. 

We are glad to report that 115 abstracts have been accepted by an international and 

independent review committee. Part of these best rated abstracts has been accepted for 

oral presentation, but the majority of abstracts will be presented during moderated poster 

sessions. 

For non-Austrian poster presenters, whose abstracts have been evaluated within the upper 

20 % of quality, a travel and hotel refund of 300 € will be given. Moreover, the three 

best rated abstracts will receive a certificate and be awarded with 1000, 500 and 300 

€, respectively. 

During the meeting we shall offer special training courses for poster and slide presentation 

as well as for the writing of scientific manuscripts. 

We hope that these innovations compared to the prior ALPE ADRIA Cardiology meetings 

will be accepted, stimulate the participation of young scientists, and guarantee a well 

visited and interesting congress full of information and discussion. 

In the name of my co-organizers I would also like to thank the members of the scientific 

board for their excellent and active cooperation, which made this meeting possible 

and will contribute to the success of the 18 th International Meeting of the ALPE ADRIA 

Association of Cardiology. 

Kurt Huber, MD, FESC, FACC 

(for the organizers) Vienna, July 2010 

www.cardio-congress.com 

2

Meeting Organization 

Local Organization 

Kurt HUBER (organizer) 

Andrea PODCZECK-SCHWEIGHOFER (co-organizer) 

Peter SMETANA (secretary clinical science) 

Johann WOJTA (secretary basic science) 

Scientific Board 

Johannes BRACHMANN (Germany) 

Miklos CSANADY (Hungary) 

Paolo FIORETTI (Italy) 

Zlatko FRAS (Slovenia) 

Francesco FURLANELLO (Italy) 

László GELLÉR (Hungary) 

Eva GONCALVESOVÁ (Slovakia) 

Bernd-Dieter GONSKA (Germany) 

Robert HATALA (Slovakia) 

Dieter HORSTKOTTE (Germany) 

Jaromir HRADEC (Czech Republic) 

Kurt HUBER (Austria) 

Miran KENDA (Slovenia) 

Bernd LÜDERITZ (Germany) 

Bela MERKELY (Hungary) 

Davor MILICIC (Croatia) 

Miodrag OSTOJIC (Serbia) 

Dubravko PETRAC (Croatia) 

Andrea PODCZECK-SCHWEIGHOFER 

(Austria) 

Alessandro PROCLEMER (Italy) 

Peter RAKOVEC (Slovenia) 

Igor RIECANSKY (Slovakia) 

Robert SCHWINGER (Germany) 

Helmut SCHÜHLEN (Germany) 

Gianfranco SINAGRA (Italy) 

Peter SMETANA (Austria) 

Jindrich SPINAR (Czech Republic) 

Stefan SPITZER (Germany) 

Konrad STEINBACH (Austria) 

Johann WOJTA (Austria) 

3

General Information 

Local Organisation 

Kurt Huber, MD, FESC, FACC 

Director, 3 rd Department of Medicine 

Cardiology & Emergency Medicine, Wilhelminenhospital 

Montleartstrasse 37, A-1160 Vienna, Austria 

Tel.: (+43/1) 49 150-2301, Fax: (+43/1) 49 150-2309 

e-mail: kurt.huber@wienkav.at 

Scientific Secretariat 

Contact.: Ms. Barbara Novak 

Tel.: (+43/1) 49 150-2307, Fax.: (+43/1) 49150-2309 

e-mail: barbara.novak@gmx.com 

Congress Secretariat 

Congress and Study Concept GesmbH 

Widerhoferplatz 4/3/19, A-1090 Vienna, Austria 

Contact: Ms. Mag. Franziska Beckmann 

Tel./Fax: (+43/1) 276 38 46 

e-mail: csconcept@chello.at 

Medical Exhibition and Advertising 

Medizinische Ausstellungs- und Werbegesellschaft 

Freyung 6, A-1014 Vienna, Austria 

Contact: Ms. Sonja Chmella 

Tel.: (+43/1) 536 63-32, Fax: (+43/1) 535 60 16 

e-mail: maw@media.co.at, www.maw.co.at 

Venue 

Old General Hospital – Campus 

Spitalgasse 2 

A-1090 Vienna, Austria 

Congress Fee 

€ 200.–; reduced fee for physicians in education 

(written confirmation); students have free access 

4

Information for Poster Presenters and Speakers 

Poster Preparation 

Posters (130x90 cm, heigth x width) have to be mounted at least 

2 hours before the presentation (material for fixation will be provided) 

and have to be removed at 6:00 PM at the same day. Otherwise, 

posters will be removed and disposed of by the staff. 

Poster Presentation 

Poster presenters have to be at their poster at the given times for 

the respective moderated poster sessions. Poster presenters have 

3 minutes for presentation of their scientific data and 3 minutes for 

discussion. 

Speaker’s Information 

Video beamers for power point presentation and laptops (PCs) are 

standard in the lecture rooms. 

We ask all speakers to present their power point presentations at least 

1 hour before the respective session at the Speakers Ready Room. 

In case you use special programs or movies please take your own 

computer with you and contact the room technician in the break 

before your session. 

Presentation of old fashiones slides will not be possible. 

5

Program Thursday, September 16, 2010 

12:45 Welcome 

K. Huber (AT) 

13:00–14:00 Lunch-Satellite Symposium 1: 

Indications for New Antithrombins 

(partially sponsored by Boehringer Ingelheim) 

chairs: D. Milicic (HR), P. Smetana (AT) 

• Acute Coronary Syndromes 

G. Christ (AT) 

• Atrial Fibrillation: Will Dabigatran Beat VKA? 

What Are the Real Indications? 

K. Huber (AT) 

parallel session, Lecture Room 2 

13:00–14:00 How-to Session for Young Investigators: How to 

Prepare an Abstract / Poster / Oral Presentation 

S. Kastl (AT) 

14:00–15:30 Symposium I: Atrial Fibrillation Update 

chairs: K. Steinbach (AT), A. Proclemer (IT) 

• Rhythm vs. Rate Control 2010 

R. Hatala (SK) 

• Innovations in Medical Management of AF 

T. Lewalter (DE) 

• New Ablation Techniques 

L. Angelkov (YU) 

• MRI in AF Ablation 

J. Brachmann (DE) 

• Robotic Navigation: First Experience 

After More Than 50 Cases 

R. Hofmann (AT) 

6


15:30–16:30 Break, Exhibition, Moderated Poster Sessions A 

16:30–18:00 Symposium II: Non-Coronary Interventions 

(partially supported by ABBOTT Cardiovascular Austria) 

chairs: M. Csanádi (HU), D. Horstkotte (DE) 

• Percutaneous Transluminal Septal Myocardium 

Ablation (PTSMA) in HOCM: 

Hemodynamic and Functional Results 

R. Sepp (HU) 

• Transcutaneous Aortic Valve Replacement 

S. Windecker (CH) 

• Transcutaneous Mitral Valve Repair 

O. Franzen (DE) 

• Best Abstract: Asymptomatic Microembolic 

Cerebral Lesions Unmasked by Magnetic 

Resonance Imaging After Transcatheter Aortic 

Valve Implantation 

S. Blazek (AT) 

7


18:00–19:30 Evening-Satellite Symposium 1: 

New Devices for Coronary Interventions 

(sponsored by BIOMEDICA, BIOSENSE/Zodl, AMACORD, 

ABBOTT Vascular, and CORDIS/Johnson&Johnson) 

Chairs: D. Horstkotte (DE), H. Schühlen (DE) 

• A New Technological Solution for Patients at High 

Risk of Thrombotic Events 

G. Christ (AT) 

• From Biodegradable Polymer Stents to Polymer Free 

Stents – Insights Into the LEADERS and 

BIOFREEDOM FIM Trials 

S. Windecker (CH) 

• The YUKON CHOICE Experience 

H. Schühlen (DE) 

• Fighting Stent Thrombosis with XIENCE DES 

T. Brunner (AT) 

• NEVO RES Technology 

C. Wolf (AT) 

• EXO SEAL Vascular Closure Device: 

New Technology, First Experience 

P. Vock (AT) 

19:30 AAAC Board Meeting 

(location to be determined) 

20:30 Presidential Dinner 

(location to be determined) 

8

Program Friday, September 17, 2010 

08:30–10:00 Symposium III – Diabetes and the Heart 

chairs: M. Kenda (SI), J. Spinar (CS) 

• How to Detect Patients with Disorders in Glucose 

Metabolism? 

S. Farhan (AT) 

• Metabolic Syndrome in Patients with STEMI Treated 

by Primary PCI 

M. Ostojic (YU) 

• Significant CAD and Diabetes: CABG or PCI? 

–pro CABG 

M. Grimm (AT) 

–pro PCI 

P. Widimsky (CZ) 

• Best Abstract: Benefit of Omega-3 Fatty Acids 

Supplementation Demonstrated in Early Stage of 

Diabetes 

J. Radosinska (SK) 

10:00–11:00 Coffee Break, Exhibition, Poster Sessions B 

11:00–13:00 Symposium IV – Networks for Myocardial Infarction 

chairs: K. Huber (AT), P. Widimsky (CS) 

• Update of MI Network Results from Northern Italy 

P. Fioretti (IT) 

• Networks for STEMI in Croatia 

D. Milicic (HR) 

• The Vienna STEMI Network 

K. Huber (AT) 

• Logistics of STEMI Management in Czech Republic 

P. Widimisky (CS) 

• Developments in Serbia 

M. Ostojic (YU) 

• Networks in Hungary 

B. Merkely (HU) 

• The Slovenian STEMI Network 

I. Kranjec (SI) 

• Berlin STEMI Registry 


9


13:00–14:00 Lunch Break, Exhibition 

13:00–14:00 Lunch Satellite Symposium 2: Antiplatelet Agents 

(partially sponsored) 

chairs: D. Milicic (HR), B-D. Gonska (DE) 

• Prasugrel 

R. G. Kiss (HU) 

• Ticagrelor 

J. Spinar (CZ) 

• Thrombin Receptor Antagonists 

K. Huber (AT) 


13:00–14:00 How-to Session for Young Investigators: 

What Editors Expect from Scientific Manuscripts 

J. Wojta (AT) 

14:00–15:30 Symposium V: Acute and Chronic Heart Failure 

chairs: G. Sinagra (IT), E. Goncalvesova (SK) 

• Biomarkers in Acute and Chronic Heart Failure 

R. Latini (IT) 

• Independent Predictors of Severe In-hospital HF in 

STEMI Patients 

A. Sinkovic (SI) 

• Acute Heart Failure: Assist Systems 

R. Schwinger (DE) 

• Stem Cell Therapy for Heart Failure after MI 

M. Gyöngyösi (AT) 

• Best Abstract: Complementary Role of Copeptin and 

High-Sensitivity Troponin in Predicting Outcome 

with Stable Chronic Heart Failure 

R. Jarai (AT) 

10


15:30–16:30 Break, Exhibition, Moderated Poster Sessions C 

16:30–18:00 Symposium VI: Coronary Interventions 

(partially sponsored by ELI LILLY/DAIICHI SANKYO) 

chairs: M. Ostojic (YU), M. Kenda (SI) 

• Cardiac Ischemia and Protection – Experimental 

Approach 

B. Ostadal (CS) 

• New Aspects in Adjunctive Antithrombotic Therapy 

in Coronary Interventions 

B. Meier (CH) 

• Is There Still a Role for GP IIb/IIIa-Blockers: 

Indications and Agents 


• Best Abstract: Tailoring Individual Antiplatelet 

Therapy after Coronary Stent Implantation Has the 

Potential to Abolish Early Definite Stent Thrombosis 

in Compliant Patients 

M. Francesconi (AT) 

18:00–19:00 Evening Satellite Symposium 2: Devices – PM/ICD 

(supported by ST. JUDE Austria) 

chairs: P. Rakovec (SI), B. Merkely (HU) 

• Executing the Guidelines in ICD-Therapy: 

“Over-Treatment” or “Under-Treatment” 

T. Pezawas (AT) 

• Haemodynamic optimization in PM/ICD-patients 

M. Nürnberg (AT) 

• Barriers & Frontiers – How to Achieve 

Comprehensive Disease Management 

W. Dichtl (AT) 

11

Program Saturday, September 18, 2010 

08:30–10:00 Symposium VII: Risk Factors and Risk Factor 

Management 

chairs: J. Hradec (CS), J. Wojta (AT) 

• Challenges of Integration of Primary and Secondary 

Prevention for the Future 

Z. Fras (SI) 

• Dendritic Cells and Atherosclerosis 

A. Niessner (AT) 

• Hypertensive Patients With ACS: Risk Profile and 

Therapeutic Option 

I. Riecansky (SK) 

• Best Abstract: Plasma Adiponectin, But Not 

Asymmetric Dimethylarginine (ADMA) Level Is 

Linked Via Insulin Resistance to Endothelial 

Dysfunction in Normotensive Offspring of Subjects 

With Essential Hypertension 

B. Zizek (SI) 

10:00–11:00 Break, Exhibition, Moderated Poster Sessions D 

11:00–12:30 Symposium VIII: Selected Topics in Rhythmology 

chairs: S. Spitzer (DE), B. Merkely (HU) 

• Sports Arrhythmology 2010 

F. Furlanello (IT) 

• Catheter Ablation of VTs: About Techniques and 

Indications 

László Gellér (HU) 

• Treatment of Inappropriate Sinus Tachycardia with 

Ivabradine 

P. Rakovec (SI) 

• Best Abstract: Chronic and Acute Treatment with 

Atorvastatin and Omega-3 Fatty Acids Protects from 

Malignant Arrhythmias. Are Intercellular Connexin 

Channels Implicated? 

N. Tribulova (SK) 

12

Program Saturday, September 18, 2010 

13:00–14:00 Lunch Satellite Symposium 3: “New Developments 

in the Therapy of Atrial Fibrillation” 

chair: R. Hatala (SK) 

(partially sponsored by SANOFI-AVENTIS Austria) 

• Atrial Remodelling in Atrial Fibrillation: Mechansim 

and Implications. 

N. Jost (HU) 

• Atrial Fibrillation – Diagnostics and Therapy: 

Dronedarone – A Paradigm Shift? 

B. Lüderitz (DE) 

• Atrial Fibrillation Meets Heart Failure – 

A Challenging Couple 

A. Podczeck-Schweighofer (AT) 


13:00–14:00 How to Session: Selection of the Patients for 

ICD/CRT Implantation 

G. Sinagra (IT) 

14:00–15:30 Symposium IX: CRT and ICD 

chairs: A. Podczeck-Schweighofer (AT), 

B. Lüderitz (DE) 

• CRT Indications: What Is New? 

B. Merkely (HU) 

• Clinical Use of Telemedicine in Cardiology 

G. Milasinovic (YU) 

• ICD Implantation in the Elderly 

D. Petrac (HR) 

• Best Abstract: Shock Burden and Efficacy of 

Antitachycardia Pacing in Patients with Implantable 

Cardiovertert Defibrillator Showing Multiple 

Ventricular Tachycardia Morphologies During Long- 

Term Follow-Up 

E. Nagy-Balo (HU) 

15:30 Farewell 

Andrea Podczeck-Schweighofer (AT) 

13

Poster Presentation Times 

Thursday, September 16, 15.30 – 16.30 

A1: Atrial Fibrillation I 

A2: Cases I 

A3: Rhythmology 

A4: Risk Factor Management I 

Friday, September 17, 10.00 – 11.00 

B1: Heart Failure I 

B2: Interventional Cardiology I 

B3: Interventional Cardiology II 

B4: Risk Factor Management II 

Friday, September 17, 15.30 – 16.30 

C1: Acute Coronary Syndromes I 

C2 Antithrombotic Therapy 

C3 Cases II 

C4 Heart Failure II 

Saturday, September 18, 10.00 – 11.00 

D1: Acute Coronary Syndromes II 

D2: Atrial Fibrillation II 

D3: Cases III 

D4: Heart Failure III 

14

Moderated Posters 

A1: Atrial Fibrillation I 

A 1 – 1 Clinical predictors of late arrhythmia recurrence following pulmonary vein 

isolation for atrial fibrillation 

G. Klausz1, V. Traykov1, R. Pap1, Á. Fodor1, G. Bencsik1, A. Makai1, L. Sághy1, 

T. Forster1 

1 2 nd Department of Internal Medicine and Cardiology Centre, University of Szeged, Faculty of 

Medicine, Szeged, Hungary 

A 1 – 2 Impact of pulmonary vein triggers on spatial distribution of dominant frequencies 

during paroxysmal atrial fibrillation. 

VB. Traykov1, R. Pap1, R. Gallardo1, J. Moss2, G. Klausz1, D. Frankel2, H. Haqqani2, 

E. Anter2, T. Forster1, L. Sághy1, DJ. Callans2 

1 Second Department of Internal Medicine and Cardiology Centre, University of Szeged, 

Hungary 

2 Hospital of the University of Pennsylvania, Philadelphia, PA, USA 

A 1 – 3 Effect Of Left Atrial Radiofrequency Ablation On The Esophagus Using A Novel 

Three-dimensional Ablation Catheter Family 

D. Tint1, ZS. Toth1, E. Nagy-Balo1, I. Beke1, M. Clemens1, I. Edes1, Z. Csanadi1 

1 Department of Cardiology, the University of Debrecen, Debrecen, Hungary 

A 1 – 4 Pulmonary vein isolation with Mesh Ablator versus Cryoballoon: six-month 

results 

R. Hofmann1, C. Steinwender1, S. Hoenig1, F. Leisch1 

1 City Hospital Linz, Austria 

A 1 – 5 Predictive Value of Plasma von Willebrand Factor and ADAMTS13 as Markers of 

Endothelial Dysfunction in Patients with Atrial Fibrillation 

MK. Freynhofer1, S. Gruber1, V. Bruno1, R. Jarai1, I. Brozovic1, 

T. Hoechtl1, S. Farhan1, G. Zorn2, J. Wojta2, K. Huber1 

1 3 rd Medical Department, Cardiology and Emergency Medicine, Wilhelminenhospital, 

Vienna, Austria 

2 Department of Cardiology, Medical University of Vienna, Austria 

A 1 – 6 Cryoballon pulmonary vein isolation in patients with symptomatic paroxysmal 

atrial fibrillation, mid-term follow-up 

C. Földesi1, A. Kardos1, A. Mihálcz1, P. Ábrahám1, Z. Som1, A. Csillik1, 

J. Borbola1, J. Ványi1, T. Szili-Török2 

1 „Gottsegen György” Hungarian Institute of Cardiology, Budapest, Hungary 

2 Thoraxcentrum, Erasmus MC, Rotterdam, The Netherlands 

15


A2: Cases I 

A 2 – 1 From the neurologist to the heart surgeon: a peripartum endocarditis, as a cause 

of stroke – case report 

A. Darago1, S. Sipka jr.1, T. Szerafin2, L. Palotas2, T. Csepany3, L. Csiba3, I. Edes1 

1 Cardiology Department, Medical Health and Science Center, University of Debrecen, 

Hungary 

2 Heart Surgery Department, Medical Health and Science Center, University of Debrecen, 

Hungary 

3 Neurology Department, Medical Health and Science Center, University of Debrecen, 

Hungary 

A 2 – 2 Recurrent Multiple Pulmonary Vein Stenoses Following Catheter Ablation of 

Paroxysmal Atrial Fibrilation 

S. Kudrnova1, L. Geller1, A. Apor1 

1 SE Heart Centre Budapest, Hungary 

A 2 – 3 Shock syndrome after aorto-intestinal fistula – case report 

M. Marinsek1, A. Sinkovic1 

1 Medical Intensive Care Unit, University Medical Centre Maribor, Slovenia 

A 2 – 4 Acute AV block following chronic infection 

V. Wagner1, E. Zima1, T. Tahin1, L. Molnár1, Á. Király1, L. Gellér1, B. Merkely1 

1 Semmelweis University Heart Center, Budapest, Hungary 

A 2 – 5 Repeatedly reversible right phrenic nerve injury following 

endocardial radiofrequency and cryothermal ablation of inappropriate sinus tachycardia 

I. Osztheimer1, SZ. Szilágyi1, G. Széplaki1, T. Tahin1, B. Merkely1, M. György1, 

T. Szili-Török2, L. Gellér1 

1 Semmelweis University, Heart Center, Budapest, Hungary 

2 Thoraxcentrum, Erasmsus MC, Rotterdam, The Netherlands 

A 2 – 6 Aortic dissection as part of the spectrum of Autosomal-dominant polycystic 

kidney disease (ADPKD). 

A. Kertész1, E. Lizanecz1, A. Horváth2, A. Leny2, I. Hegedus1, I. Édes1 

1 University of Debrecen, Institute of Cardiology, Hungary 

2 University of Debrecen, Institute of Cardiology, Heart Surgery Centre, Hungary 

A 2 – 7 Tricuspid regurgitation after horse s hoof kick into the chest 

D. Suran1, I. Balevski1, V. Kanic1, M. Miksic1, B. Kosmac2 

1 University Clinical Center Maribor, Slovenia 

2 University Clinical Center Ljubljana, Slovenia 

A 2 – 8 Catecholamin induced cardiomyopathy – case report 

A. Strdin Kosir1, M. Marinsek1 

1 University Medical Centre Maribor, Slovenia 

16


A3: Rhythmology 

A 3 – 1 Intravenous amiodarone induced acute liver failure: retrospective study of 3 

years of Semmelweis University Heart Center 

E. Zima1, T. Barany1, V. Szabo1, V. Wagner1, I. Osztheimer1, L. Molnar1, SZ. Szilagyi1, 

D. Becker1, L. Geller1, B. Merkely1 


A 3 – 2 Clinical profile of patients with an early occurence of a serious arrhythmic event 

after myocardial infarction 

M. Svetlosak1, P. Mabo2, C. Leclercq2, R. Martins2, JC. Daubert2, R. Hatala1 

1 Department of Arrhythmias and Cardiac Pacing, National Institute of Cardiovascular 

Diseases, Bratislava, Slovakia 

2 Service de Cardiologie et CIT-IC 804, LTSI INSERM U 642, Centre Hospitalier Universitaire, 

Rennes, France 

A 3 – 3 Comparison of minimal myocardial damage after single and dual chamber 

pacemaker implantation. 

T. Hnatek1, L. Kameník1, P. Sedlon1, J. Luxová1, B. Steuerová1, M. Cernohous1, 

M. Zavoral1 

1 Department of Cardiology, Internal Medicine Clinic, 1st Faculty of Medicine, Charles 

University in Prague, Czech Republic 

A 3 – 4 Telemonitoring of pacemaker / ICD patients: investigation of technologic 

possibilities of Home Monitoring 

T. Barany1, G. Szucs1, SZ. Szilagyi1, L. Molnar1, L. Geller1, B. Merkely1, E. Zima1 

1 Semmelweis University - Heart Center, Budapest, Hungary 

A 3 – 5 Six years experience of a low volume electrophysiology centre in Hungary 

DR. Hajkó1, DR. Geller2, DR. Szucs1, DR. Valco1, DR. Káposztás1 

1 Cardiology Department Cegled, Hungary 

2 Cardiology Centre Semmelweis University, Budapest, Hungary 

A 3 – 6 Atrial Fibrillation: Early Observations With Pulmonary Vein Ablation Catheter 

(PVAC) 

D. Ruzsa1, B. Ruzsics1, B. Manfai1, P. Rausch1, T. Simor1 

1 Heart Institute, Faculty of Medicine, University of Pécs, Hungary 

17


A4: Risk Factor Management I 

A 4 – 1 Cellular mechanisms involved in cardioprotective-antiarrhyhmic effects of 

omega-3 fatty acids in young and old spontaneously hypertensive rats. 

B. Bacova1, J. Radosinska1, V. Knezl2, M. Barancik1, P. Weismann3, N. Tribulova1 

1 Institute for Heart Research, SAS, Bratislava, Slovak Republik 

2 Institute of Exp. Pharmacology and Toxicology, SAS, Bratislava, Slovak Republik 

3 Medical Faculty of Comenius University, Bratislava, Slovak Republik 

A 4 – 2 Effects of coronary revascularization with or without cardiopulmonary bypass on 

plasma levels of the endogenous nitric oxide synthase inhibitor ADMA 

ZS. Lenkey1, A. Cziráki1, Á. Németh1, Z. Ajtay1, N. Alotti2, S. Szabados1, 

I. Horváth1, JM. Lobenhoffer3, SM. Bode-Böger3 

1 Heart Institute, Faculty of Medicine, University of Pécs, Hungary 

2 Department of Cardiac Surgery, Zala County Hospital, Hungary 

3 Institute of Clinical Pharmacology, University Hospital, Otto-von-Guericke University, 

Hungary 

A 4 – 3 Coronary flow velocity reserve is an independent predictor of long-term 

event-free survival in non-diabetic patients with normal epicardial coronary arteries 

A. Nemes1, E. Balazs1, KS. Pinter1, A. Egyed1, M. Csanady1, T. Forster1 

1 2 nd Department of Medicine and Cardiology Center, University of Szeged, Szeged, Hungary 

A 4 – 4 Regional (continental versus Mediterranean) behavioral and interim cardiovascular 

risk factor characteristics of Croatian hospitalized coronary heart disease patients 

H. Vrazic1, J. Sikic1, T. Lucijanic1, M. Raguz1, B. Starcevic1, I. Rajcan Spoljaric1, A. 

Romic2, P. Samardzic2, S. Polic2, N. Jukic2, D. Trsinski2, L. Zaputovic2, J. Mirat2, 

M. Bergovec1 

1 School of Medicine (University of Zagreb) and Department of Cardiology (University 

Hospital Dubrava), Zagreb, Croatia 

2 School of Medicine, University of Zagreb, Zagreb, Croatia 

A 4 – 5 Psychosocial characteristis of hospitalized patients (male vs. female) with 

coronary heart disease in Croatia 

J. Sikic1, H. Vrazic1, T. Lucijanic1, B. Starcevic1, M. Raguz1, I. Rajcan Spoljaric1, A. 

Romic2, K. Boric2, M. Padovan2, J. Grman2, A. Knezevic2, K. Sutalo 2, M. Ivanusa2, M. 

Bergovec1 

1 School of Medicine (University of Zagreb) and Department of cardiology (University 

Hospital Dubrava) Zagreb, Croatia 

2 School of Medicine, University of Zagreb, Zagreb, Croatia 

18

Moderated Posters1 

A 4 – 6 Physiologic left ventricular hypertrophy and remodelling in elite athletes 

V. Kutyifa1, A. Apor1, A. Szucs1, A. Nagy1, E. Édes1, B. Merkely1 


B1: Heart Failure I 

B 1 – 1 Prevalence of sarcomeric gene mutations in Hungarian patients with 

hypertrophic cardiomyopathy 

R. Sepp1, L. Losonczi2, T. Tóth1, V. Nagy1, A. Orosz1, K. Kádár3, M. Hogye1, GY. Fekete2, 

M. Csanády1, T. Forster1 

1 2 nd Department of Internal Medicine and Cardiology Center, University of Szeged, Hungary 

2 2 nd Department of Pediatrics, Semmelweis University, Budapest, Hungary 

3 Gottsegen György National Institute of Cardiology, Budapest, Hungary 

B 1 – 2 The Gln1233ter alteration of the myosin binding protein C gene (MYBPC3) in 

hypertrophic cardiomyopathy: causative mutation or innocent polymorphism? 

T. Tóth1, V. Nagy1, R. Faludi2, M. Hogye1, M. Csanády1, T. Simor2, T. Forster1, R. Sepp1 

1 2 nd Department of Internal Medicine and Cardiology Center, University of Szeged, Hungary 

2 Heart Institute, University of Pécs, Hungary 

B 1 – 3 Diastolic dysfunction may cause heart failure symptoms in patients 

hyperresponder to cardiac resynchronization therapy. 

M. Clemens1, O. Bene1, A. Kertész1, ZS. Tóth1, CS. Herczku1, I. Édes1, Z. Csanádi1 

1 Dept. of Cardiology, University of Debrecen, Hungary 

B 1 – 4 Association of NT-pro Brain Natriuretic Peptide levels and echocardiographic 

variables in longterm heart transplant recipients 

B. Stanek1, J. Renoldner1, R. Berger1, S. Rödler2, A. Aliabadi2, A. Zuckermann2, 

J. Bergler-Klein1 

1 University of Vienna, Internal Medicine II, Cardiology, Vienna, Austria 

2 University of Vienna, Cardiothoracic Surgery, Vienna, Austria 

B 1 – 5 The potential role of ultra-sensitive troponin-determination in chronic stable 

heart failure 

R. Jarai1, L. Leherbauer1, I. Tentzeris1, S. Farhan1, M. Schwarz1, 

G. Jakl1, K. Huber1 

1 3 rd Dept. of Medicine, Cardiology and Emergency Medicine, Wilhelminenhospital, Vienna, 

Austria 

19


B 1 – 6 Custodiol-N, the novel cardioplegic solution reduces ischemia/reperfusion injury 

after cardiopulmonary bypass 

G. Veres1, T. Radovits1, F. Horkay2, G. Szabó3 

1 Department of Cardiac Surgery, University of Heidelberg, Heidelberg, Germany and 

Department of Cardiac Surgery, Semmelweis University, Budapest, Hungary 

2 Department of Cardiac Surgery, Semmelweis University, Budapest, Hungary 

3 Department of Cardiac Surgery, University of Heidelberg, Germany 

B 1 – 7 Copeptin and Nt-proBNP as Precitors of Post-operative Outcome in Patients with 

Major Vascular Surgery 

R. Jarai1, E. Mahla2, S. Archan2, K. Huber1, H. Metzler2 

1 3 rd. Dept. of Medicine, Cardiology and Emergency Medicine, Wilhelminenhospital, Vienna, 

Austria 

2 Department of Anesthesiology and Intensive Care Medicine, Medical University, Graz, Austria 

B 1 – 8 Predictors of in-hospital mortality in patients hospitalized for acute heart failure 

in Slovakia. 

I. Varga1, P. Solik1, P. Lesny1, M. Luknar1, B. Liska1, S. Babej1, E. Goncalvesova1 

1 National Institute of Cardiovascular Diseases, Bratislava, Slovak Republic 

B2: Interventional Cardiology I 

B 2 – 1 The adipokine vaspin inhibits smooth muscle migration in vitro and the development 

of coronary in-stent restenosis in vivo 

SP. Kastl1, KM. Katsaros2, KA. Krychtiuk1, G. Maurer1, K. Huber3, J. Wojta1, WS. Speidl1 

1 Medical University of Vienna, Department of Internal Medicine II, Division of Cardiology, 


2 Kaiserin-Elisabeth-Spital, Department of Internal Medicine, Vienna, Austria 

3 3 rd. Medical Department, Cardiology and Emergency Medicine, Wilhelminenhospital, 


B 2 – 2 Impact of pre-operative clopidogrel administration in patients undergoing cardiac 

surgery 

A. Vorobcsuk1, D. Aradi2, K. Farkasfalvi1, I G. Horváth2, A. Komócsi2 

1 University of Pécs, Heart Institute, Department of Cardiovascular Intensive Care, Hungary 

2 University of Pécs, Heart Institute, Department of Interventional Cardiology, Hungary 

B 2 – 3 Periprocedural complications of elective coronary angiography and/or PCI 

V. Novotny1, J. Matejka1, P. Vojtisek1, I. Varvarovsky2, V. Rozsival2, A. Herman2, 

M. Riegrova3 

1 Cardiology, Regional Hospital Pardubice, Czech Republic 

2 Kardio-Troll, Pardubice, Czech Republic 

3 Faculty of Health Studies, Pardubice, Czech Republic 

20


B 2 – 4 Repeated restenosis after drug-eluting stent implantation for bare metal in-stent 

restenosis 

B. Berta1, GY. Barczi1, D. Becker1, L. Geller1, Z. Jambrik1, L. Molnar1, SZ. Pali1, 

Z. Ruzsa1, GY. Szabo1, B. Merkely1 


B 2 – 5 Influence of lesion morphology on functional severity of coronary stenoses 

T. Szucsborus1, I. Ungi1, A. Thury1, T. Keresztes1, T. Forster2 

1 University of Szeged, Invasive Cardiology Department, Hungary 

2 University of Szeged, Second Department of Internal Medicine and Cardiological Center, 

Hungary 

B 2 – 6 Permanent pacemaker requirement after transcatheter aortic valve implantation 

R. Maier1, R. Hoedl1, G. Stoschitzky1, M. Grabenwoeger2, J. Pollak2, N. Watzinger1, 

S. Blazek1, D. Paetzold1, P. Oberwalder1, B. Pieske1, O. Luha1 

1 Medical University Graz, Dept of Medicine, Div of Cardiology, Graz, Austria 

2 Hospital Hietzing, Department of Cardiology, Vienna, Austria 

B 2 – 7 X-ray dose, blood loss, dose of radiocontrast agent and renal function in a series 

of 100 consecutive transcatheter aortic valve implantation patients 

R. Hödl1, S. Schmidt1, O. Luha1, G. Stischitzky1, B. Pieske1, N. Watzinger1, R. Maier1 

1 Medical University Graz, Dept of Medicine, Div of Cardiology, Graz, Austria 

B3: Interventional Cardiology II 

B 3 – 1 The influence of on-pump and off-pump coronary artery bypass grafting (CABG) 

on hemorheological parameters 

J. Papp1, A. Toth1, B. Sandor1, R. Kiss2, M. Rabai1, P. Kenyeres1, S. Szabados2, K. Toth1 

1 1 st Department of Medicine, University of Pécs, School of Medicine, Hungary 

2 Heart Institute, University of Pécs, School of Medicine, Hungary 

B 3 – 2 Transradial approach for coronary angiography and interventions. Our experience 

on first 500 patients 

A. Jovic1, J. Patrk1, D. Zekanovic1 

1 Cardiology Dept. General Hospital Zadar, Croatia 

B 3 – 3 Ballon aortic valvulaplasty in severe aortic stenosis in elderly 

P. Kogoj1, K. Azman Juvan1, S. Music1, J. Ambrozic1, B. Kontestabile1, D. Zorman1, 

M. Bunc1 

1 University Medical Centre Ljubljana, Slovenia 

21


B 3 – 4 Comparison of the Leaman weighing factor and the Holistic Coronary Care 

Software on the basis of autopsy findings 

GT. Szabo1, R. Kolozsvari1, I. Racz1, P. Gergely2, K. Racz2, B. Borsay2, L. Herczeg2, 

I. Edes1, ZS. Koszegi1 

1 UDMHSC Institute of Cardiology, Budapest, Hungary 

2 UDMHSC Institute of Forensic Medicine, Budapest, Hungary 

B 3 – 5 The first results of chronic total occlusions program in Szeged 

U. Kiddy Levente1, E. Balázs1, A. Thury1, T. Forster1, I. Ungi1 

1 University of Szeged, Hungary 

B4: Risk Factor Management II 

B 4 – 1 Investigation of classic risk factors and coagulation factor XIII in young 

myocardial infarction patients 

L. Balogh1, Z. Mezei2, ZS. Bereczky2, I. Édes1, L. Muszbek2 

1 University of Debrecen, Medical Health Science Center, Institute of Cardiology, Hungary 

2 University of Debrecen, Medical Health Science Center, Clinical Research Center, Hungary 

B 4 – 2 Correlation between flow-mediated vasodilatation of the brachial artery and 

intima-media thickness in the carotid artery in hypertensive patients 

C. Serban1, S. Dragan1, I. Mozos1, L. Susan1, R. Christodorescu1, A. Caraba1, A. 

Pacurari1, R. Mateescu1, G. Savoiu1, I. Romosan1 

1 University of Medicine and Pharmacy Victor Babes, Timisoara, Romania 

B 4 – 3 The Mediterranean versus the continent: regional differences in selected risk 

factors in Croatian coronary heart disease patients 

M. Bergovec1, Z. Reiner2, D. Milicic3, H. Vrazic1 

1 Department of Cardiology, University Hospital Dubrava, Zagreb, Croatia 

2 Department of Internal Medicine, University Hospital Center Zagreb, Croatia 

3 Department of Cardiovascular Diseases, University Hospital Center Zagreb, Croatia 

B 4 – 4 Increased plasma level of lipoprotein (a) is a marker of increased 

cardiovascular risk 

D. Ljubicic1, M. Raguz2, I. Rajcan Spoljaric2, H. Vrazic2, T. Lucijanic2, S. Sokol2, 

V. Raos2, M. Bergovec2 

1 Department of Internal Medicine, University Hospital Center Zagreb, Croatia 


B 4 – 5 The results of Rogers’ small group method in cardiac rehabilitation 

DR. Gyöngyvér Ferencz1, MS. Katalin Kecskeméti1, PHD. Gábor Andrássy1 

1 St. Francis Hospital, Budapest, Hungary 

22


B 4 – 6 New indexes for estimating dyslipidemic risk in hypertensive patients 

C. Serban1, S. Dragan1, I. Mozos1, L. Susan1, R. Christodorescu1, A. Pacurari1, 

G. Savoiu1, I. Romosan1 

1 University of Medicine and Pharmacy Victor Babes, Timisoara, Romania 

B 4 – 7 Evaluation of arterial hypertension control with antihypertensive drugs 

D. Dobovsek1, M. Bunc1 

1 University Medical Centre Ljubljana, Ljubljana, Slovenia 

B 4 – 8 Risk management of diabetic patients with cardiovascular diseases at the 

beginning of the inhospital cardiac rehabilitation programme 

T É. Kóródi1, É. Simon2, B. Bálint3, A. Simon4 

1 Dept. of. Cardiovasc. Rehab., Székesfehérvár, Hungary 

2 Cardio-Rehab., Sopron, Hungary 

3 Rehab. of Cardio-pulmo., Deszk, Hungary 

4 Cardiac Center, Balatonfüred, Hungary 

C1: Acute Coronary Syndromes I 

C 1 – 1 Prediction of cardiogenic shock using plasma Nt-proBNP concentrations in 

ST-elevation myocardial infarction: A substudy of ASSENT IV-PCI 

R. Jarai1, K. Huber1, K. Bogaerts2, P. Armstrong3, F. Van de Werf4 

1 3 rd Med. Department, Cardiology and Emergency Medicine, Wilhelminenhospital, Vienna, 

Austria 

2 I-Biostat, Katholieke Universiteit Leuven, Leuven, Belgium and Universiteit Hasselt, 

Belgium 

3 Division of Cardiology, University of Alberta, Edmonton, Canada 

4 Department of Cardiology, University Hospital Gasthuisberg, Leuven, Belgium 

C 1 – 2 Routine Determination of Platelet Reactivity in Patients on Long-term Dual 

Antiplatelet Therapy: The WILMAA Registry 

MK. Freynhofer1, I. Brozovic1, V. Bruno1, L. Yukhanyan1, L. Leherbauer1, M. Djurkovic1, 

R. Jarai1, M. Willheim2, W. Huebl2, J. Wojta3, K. Huber1 

1 3 rd Med. Department, Cardiology and Emergency Medicine, Wilhelminenhospital, Vienna, 

Austria 

2 Department of Laboratory Medicine, Wilhelminenhospital, Vienna, Austria 

3 Department of Cardiology, Medical University of Vienna, Vienna, Austria 

C 1 – 3 In patients with history of infection followed by cardiac symptoms analysis of 

global strain with 2D-speckle-tracking allows to diagnose acute coronary syndrome, but 

not myocarditis. 

T. Hafner1, K. Gammer1, R. Böck1, S. Hoffmann1, B. Horvath-Mechtler2, C. Krammer2, 

G. Strau2, W. Kumpan2, A. Podczeck-Schweighofer1 

1 Dept. of Cardiology, Kaiser Franz Josef Spital, Vienna, Austria 

2 Dept. of Radiology, Kaiser Franz Josef Spital, Vienna, Austria 

23


C 1 – 4 The medical treatment of the Acute Coronary Syndrome (ACS) in Styria. 

Presentation of the data collected in the Styrian ACS registry from 2006 to 2008 

M. Suppan1, H. Brussee2, K. Mathyas2, R. Maier2, R. Zweiker2, M. Grisold2, O. Luha2, 

I. Kienzl2, B. Pieske2, N. Watzinger2 

1 University of Medicine Graz, Clinical Department of Cardiology and Dept. of Cardiology, 

Wels-Grieskirchen, Austria 

2 University of Medicine Graz, Clinical Department of Cardiology, Austria 

C 1 – 5 Independent predictors of in-hospital heart failure in patients with ST-elevation 

myocardial infarction. 

A. Sinkovic1, F. Svensek1 

1 University clinical centre Maribor, Slovenia 

C 1 – 6 Dynamics and relationship of selected markers of inflammation in different 

forms of acute coronary syndrome 

H. Vrazic1, M. Raguz1, I. Rajcan Spoljaric1, B. Peric1, T. Lucijanic1, V. Raos1, S. Sokol1, 

K. Matic2, T. Bozin2, I. Subjak2, M. Bergovec1 


2 School of Medicine, University of Zagreb, Croatia 

C 1 – 7 Hypertensive patients with acute coronary syndrome – risk profile and 

therapeutic option 

I. Riecansky1, J. Pacak1, J. Malik1 

1 Department of Cardiology National Institute of Cardiovascular Diseases, Bratislava, 

Slovakia 

C 1 – 8 Real-time three-dimensional stress echocardiography – Our first experiences 

A. Nemes1, ML. Geleijnse2, BJ. Krenning2, OI. Soliman2, WB. Vletter2, JG. Bosch2, 

FJ. Ten Cate2 

1 2 nd Department of Medicine and Cardiology Center, University of Szeged, Szeged, Hungary 

2 Department of Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands 

C2: Antithrombotic Therapy 

C 2 – 1 Detection of Clopidogrel resistance by multiple electrode platelet aggregometry 

(MEA) and light transmission aggregometry (LTA) 

J. Galuszka1, L. Slavík2, M. Hutyra1, J. Úlehlová2, V. Krcová2, J. Indráková1, A. Hluší2, 

M. Táborský1 

1 First Clinic of Internal Medicine – Cardiology Clinic, Olomouc University Hospital, Czech 

Republic 

2 Coagulation Laboratory: Department of Hemato-Oncology, Olomouc University Hospital, 

Czech Republic 

24


C 2 – 2 Impact of Concomitant Treatment with Proton Pump Inhibitors and Clopidogrel 

on Clinical Outcome in Patients after Coronary Stent Implantation 

I. Tentzeris1, S. Farhan1, R. Jarai1, U. Unger1, G. Geppert1, J. Wojta2, K. Huber1 



2 Department of Cardiology, Medical University of Vienna, Austria 

C 2 – 3 Seasonal variations in hemorheological parameters and platelet aggregation – 

a possible association with meteorological factors? 

K. Koltai1, J. Papp1, P. Kenyeres1, R. Halmosi1, G. Feher2, G. Kesmarky1, L. Czopf1, 

K. Toth1 

1 1 st Department of Medicine, School of Medicine, University of Pecs, Hungary 

2 Department of Neurology, School of Medicine, University of Pecs, Hungary 

C 2 – 4 Comparison of different laboratory methods for the use of detecting aspirin 

resistance in healthy volunteers 

N. Homorodi1, E. Kovacs1, ZS. Bereczky1, L. Balogh2, G. Haramura1, L. Muszbek1, I. Edes2 

1 Institute of Cardiology, University of Debrecen, Hungary 

2 Clinical Research Centre, Hungarian Academy of Sciences, Research Group for 

Haemostasis, Thrombosis and Vascular Biology, University of Debrecen, Hungary 

C 2 – 5 Pulmonary embolism and neoplastic disease: role of initial screening in 

antithrombotic treatment options. 

S. Magnani1, S. Pyxaras1, G. Barbati2, M. Delise1, M. Valentincic1, M. Merlo1, G. Sinagra1 

1 Cardiovascular Department of Trieste, University Hospital of Trieste, Italy 

2 Department of Environmental Medicine and Public Health, University of Padua, Italy 

C3: Cases II 

C 3 – 1 Non compact cardiomyopathy in acromegaly: unique coincidence 

Z. Cserep1, AC. Nagy1, S. Szoke1, T. Simor2 

1 Uzsoki Municipal Hospital, 1 st Department of Internal Medicine and Cardiology, Budapest, 

Hungary 

2 University of Pécs, Faculty of Medicine, Hungary 

C 3 – 2 Aortic homograft implantation in a patient with Osler-Weber-Rendu disease and 

infective endocarditis of the previously implanted bioprosthesis 

DR. Tamas Habon1, DR. Laszlo Czopf1, DR. Edit Varady2, DR. Gabor Bogats3, 

PROF. Kalman Tóth1 

1 1 st Department of Medicine, Division of Cardiology, University of Pecs, Medical Center, 

Pecs, Hungary 

2 Department of Radiology, University of Pecs, Medical Center, Hungary 

3 2 nd Department of Internal Medicine and Heart Center, Division of Cardiac Surgery, 

University of Szeged, Hungary 

25


C 3 – 3 Therapeutic hypothermia after cardiac arrest: a case series 

V. Velagic1, Z. Baricevic1, B. Skoric1, J. Samardzic1, M. Cikes1, I. Irena1, D. Milicic1 

1 University Hospital Centre Zagreb, Department of Cardiovascular Diseases, Zagreb, Croatia 

C 3 – 4 Ablation of premature ventricular complexes originating from the left ventricular 

outflow tract using a novel automated pace-mapping software 

G. Széplaki1, T. Tahin1, SZ. Szilágyi1, I. Osztheimer1, K. Ladunga1, B. Merkely1, L. Gellér1 

1 Heart Centre, Semmelweis University, Budapest, Hungary 

C 3 – 5 Paradoxical base to apex gradient during IVRT in HOCM patient with right 

ventricular pacing 

J. Separovic- Hanzevacki1, V. Velagic1 

1 University Hospital Centre Zagreb, Department of Cardiovascular Diseases, Zagreb, Croatia 

C 3 – 6 Carotid body tumor in patient with Eisenmenger syndrome. 

K. Kanalikova, jr.1, J. Tomka1, K. Kanalikova2, I. Simkova2 

1 Dept. of Vascular Surgery, Nusch, Slovakia 

2 Dept. of Cardiology, Nusch, Slovakia 

C 3 – 7 Severe myositis and respiratory failure after treatment with high-dose statin and 

ezetimib – case report 

S. Kirbis1, F. Svensek1, M. Marinsek1, A. Sinkovic1 


C4: Heart Failure II 

C 4 – 1 Coronary sinus lead reposition using a minimally invasive technique for the 

treatment of phrenic nerve stimulation 

SZ. Szilagyi1, B. Merkely1, E. Zima1, L. Molnar1, T. Tahin1, I. Osztheimer1, G. Szeplaki1, 

L. Geller1 


C 4 – 2 Assessment of electrocardiographic parameters of cardiac repolarization in 

hypertrophic cardiomyopathy 

A. Orosz1, R. Sepp2, CS. Lengyel3, I. Baczkó1, M. Csanády2, T. Forster2, JGY. Papp4, 

A. Varró4 

1 Department of Pharmacology and Pharmacotherapy, University of Szeged, Hungary 

2 2 nd Department of Internal Medicine, University of Szeged, Hungary 

3 1 st Department of Internal Medicine, University of Szeged, Hungary 

4 Department of Pharmacology and Pharmacotherapy; Division of Cardiovascular 

Pharmacology, Hungarian Academy of Sciences, Szeged, Hungary 

26


C 4 – 3 Usefulness of electroanatomical mapping during transseptal endocardial left 

ventricular lead implantation 

V. Kutyifa1, B. Merkely1, SZ. Szilágyi1, L. Molnár1, E. Zima1, I. Osztheimer1, G. Széplaki1, 

L. Gellér1 


C 4 – 4 Changes in Autonomic Nervous System Activity in Hypertrophic Cardiomyopathy: 

Dependent on Body Position? 

L. Halmai1, R. Sepp2, L. Rudas1, M. Csanády2, T. Forster2 

1 University of Szeged, Medical Faculty, Department of Intensive Care Medicine, Hungary 

2 University of Szeged, Medical Faculty, Cardiology Centre, Hungary 

C 4 – 5 Retrospective analysis of survival data of in-hospital and out-of-hospital 

resuscitated patients int he practice of Semmelweis University Heart Center 

ZS. Jenei1, E. Zima1, E. Kovács1, L. Gellér1, L. Molnár1, SZ. Szilágyi1 


C 4 – 6 Brain Natriuretic Peptide nurse determined in a Heart failure Clinic: a practical 

and important tool to determine death from progressive heart failure but not sudden 

death 

FD. Cruz1, VS. Issa1, F. Bacal1, GEC. Souza1, SA. Ferreira1, EA. Bocchi1 

1 Heart Institut – InCor/HCFMUSP, São Paulo, Brasil 

C 4 – 7 Characteristics and outcomes of patients hospitalized for acute heart failure in 

Slovakia. 

P. Solik1, I. Varga1, P. Lesny1, M. Luknar1, S. Babej1, B. Liska1, E. Goncalvesova1 

1 National Institute of Cardiovascular Diseases, Bratislava, Slovakia 

D1: Acute Coronary Syndromes II 

D 1 – 1 Sex-related differences in baseline characteristics, management and outcomes 

in patients with acute coronary syndrome without ST-segment elevation (NSTE-ACS) 

B. Vogel1, S. Hahne1, I. Kozanli1, K. Kalla1, R. Jarai1, S. Farhan1, M. Nürnberg1, G. 

Unger1, A. Geppert1, K. Huber1 



D 1 – 2 Impact of acute hyperglycemia on the outcome of patients suffering ACS 

S. Farhan1, I. Tentzeris1, R. Jarai1, MK. Freynhofer1, J. Wojta2, K. Huber1 



2 University of Medicine, Department of Cardiology, Vienna, Austria 

27


D 1 – 3 New thermo- and hemodynamic-controlled active hypothermic intensive 

treatment of postresuscitated patients at Semmelweis University Heart Center 

E. Zima1, E. Kovacs1, ZS. Jenei1, T. Barany1, L. Molnar1, SZ. Szilagyi1, I. Osztheimer1, 

S. Nardai1, L. Geller1, B. Merkely1 


D 1 – 4 Influence of updated guidelines on short- and long-term mortality in patients 

with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) 

B. Vogel1, S. Hahne1, I. Kozanli1, K. Kalla1, R. Jarai1, MK. Freynhofer1, M. Nürnberg1, 

G. Unger1, A. Geppert1, K. Huber1 



D 1 – 5 The comparison of standard echocardiography with 2-dimensional ultrasonic 

strain measurements in the detection of ischemic myocardium in patients with acute 

coronary syndrome 

A. Nagy1, A. Apor1, B. Sax1, V. Wagner1, V. Kutyifa1, D. Becker1, B. Merkely1 


D 1 – 6 Changes in timing and management of NSTEMI patients in the Heart Institute, 

University of Pécs during the last 10 years 

E. Lukács1, B. Magyari1, D. Aradi1, T. Pintér1, A. Komócsi1, A. Kónyi1, I. Horváth1 

1 Heart Institute, University of Pécs, Hungary 

D 1 – 7 Levosimendan in patients with cardiogenic shock after acute myocardial 

infarction 

F. Svensek1, A. Sinkovic1 

1 University Clinical Centre Maribor, Maribor, Slovenia 

D2: Atrial Fibrillation II 

D 2 – 1 Mid-term efficacy and predictors of postablation arrhythmia recurrences in 

patients undergoing robotically-guided catheter ablation for paroxysmal atrial fibrillation 

P. Hlivak1,2, H. Mlcochova2, P. Peichl2, R. Cihak2, D. Wichterle2, J. Kautzner2 

1 National Cardiovascular Institute, Bratislava, Slovakia 

2 Institute for Clinical and Experimental Medicine, Prague, Czech Republic 

D 2 – 2 Left atrial size, function and left ventricular diastolic function after cryoballoon 

catheter ablation in patients with paroxysmal atrial fibirillation 

T. Erdei1, M. Dénes1, A. Mihálcz1, A. Kardos1, CS. Földesi1, A. Temesvári1, M. Lengyel1 

1 Gottsegen Hungarian Institute of Cardiology, Budapest, Hungary 

28


D 2 – 3 Reisolation of the Pulmonary Veins after Cryoballoon Ablation Using a Novel 

Radiofrequency Ablation Technique. 

I. Beke1, E. Nagy-Balo1, D. Tint1, M. Clemens1, ZS. Toth1, I. Edes1, Z. Csanadi1 

1 Department of Cardiology, University of Debrecen, Hungary 

D 2 – 4 The properties of the transient outward, ultra-rapid delayed rectifier and 

acetylcholine sensitive potassium currents in isolated atrial myocytes from dogs sin 

sinus rhythm and tachypaced model of chronic atrial fibrillation. 

N. Jost1, Z. Kohajda1, PP. Kovacs2, A. Kristof1, L. Virag2, I. Baczko2, A. Varro2 

1 Division of Cardiovascular Pharmacology, Hungarian Academy of Sciences, Szeged, 

Hungary 

2 Department of Pharmacology and Pharmacotherapy, University of Szeged, Faculty of 

Medicine, Hungary 

D 2 – 5 Anticoagulation therapy in chronic atrial fibrillation. What can we do for a better 

anticoagulation quality for stroke prevention in a busy Emergency Department. 

DR. Szabo1, DR. Mihaly1, DR. Erdelyi1 

1 County Hospital of Kecskemet, Emergency Department, Hungary 

D3: Cases III 

D 3 – 1 Subacute stent thrombosis: How to manage in the daily routine? 

B. Magyari1, E. Lukács1, A. Aradi1, A. Kónyi1, A. Komócsi1, T. Pintér1, I. Horváth1 

1 Heart Institute of Pécs, Department of Cardiology, Hungary 

D 3 – 2 Angina pectoris in patient with chronic calcified pericarditis and delayed 

coronary filling without obstruction of the coronary arteries - Case Report 

J. Galuszka1, D. Richter1, D. Horák2, D. Marek1, M. Cerná2, P. Folwarczny1, J. Bajorek1, 

M. Táborský1 

1 First Clinic of Internal Medicine – Cardiology Clinic, Olomouc University Hospital, Czech 

Republic 

2 Department of Radiology, Olomouc University Hospital, Czech Republic 

D 3 – 3 Patent foramen ovale diagnosed in a young male patient with acute peripheral 

arterial embolisation and recurring pulmonary embolism 

N. Kovacs1, CS. Kiraly1, A. Nagy1 

1 County Hospital Kecskemét, Dept. of Internal Med. and Cardiology, Hungary 

D 3 – 4 Mysterious inappropriate ICD shocks ending up in end of system status 

V. Wagner1, I. Oszheimer1, SZ. Szilágyi1, L. Gellér1, B. Merkely1, E. Zima1 


29


D 3 – 5 Acute heart failure after rupture of posterior leaflet of mitral valve-case report 

S. Kirbis1, F. Svensek1, A. Sinkovic1 


D 3 – 6 Patients admitted to an Internal Department during night-shift ́s hours 

M. Pernicky1, J. Murin1 

1 1 st Department of Internal Medicine, Faculty of Medicine, Comenius University, Bratislava, 

Slovakia 

D 3 – 7 Patients with chest pain - case reports 

J. Ondruskova1, E. Sovova1, Y. Hrckova1, M. Taborsky1 

1 Department of Internal Medicine I, University Hospital Olomouc, Czech Republic 

D4: Heart Failure III 

D 4 – 1 Is there separate diastolic dysfunction in hypertrophic cardiomyopathy or systole 

leads the pack? 

L. Halmai1, A. Pálinkás2, R. Sepp3, M. Csanády3, T. Forster3, A. Varga3 

1 University of Szeged, Medical Faculty, Department of Intensive Care Medicine, Hungary 

2 Erzsébet Hospital, Department of Medicine, Hodmezovasarhely, Hungary 

3 University of Szeged, Medical Faculty, Cardiology Centre, Szeged, Hungary 

D 4 – 2 Blood urea nitrogen (BUN) predicts all-cause mortality in chronic stable heart 

failure in addition to plasma Nt-proBNP and cardiac troponin T 

R. Jarai1, M. Djurkovic1, S. Farhan1, I. Tentzeris1, M. Schwarz1, G. Jakl1, K. Huber1 



D 4 – 3 Effect of an Education and Monitoring Sequential Program Over Quality-of-Life 

Components in Heart Failure 

FD. Cruz1, VS. Issa1, JR. Lanz1, LF. Moreira1, GEC. Sousa1, PR. Chizzola1, SA. Ferreira1, 

F. Bacal1, EA. Bocchi1 


D 4 – 4 The result of coronary revascularization in case of major systolic heart failure 

and chronic total coronary occlusion 

L. Vándor1, K. Heltai2 

1 Jhan Ferenc Délpest Hospital, Budapest, Hungary 


30


D 4 – 5 The influence of obstructive sleep apnea syndrome treatment applied by continuous 

positive airway pressure (CPAP) on heart function – evaluation of left and right ventricular 

TEI index and tissue Doppler imaging evaluation. 

M. Hobzova1, E. Sovova2, M. Sova3, K. Langova4, V. Kolek1, M. Taborsky2, 

J. Ondruskova2 

1 Department of Pneumology, University Hospital Palacky University 

2 Internal Department, University Hospital Palacky University 

3 Faculty of Medicine and Dentistry, Palacky University 

4 Department of Medical Biophysics, Palacky University, Olomouc, Czech Republic 

D 4 – 6 Components of Life Quality Evaluation in Heart Failure Clinic 

FD. Cruz1, VS. Issa1, SA. Ferreira1, GEC. Souza1, PR. Chizzola1, F. Bacal1, LFP. Moreira1, 

JR. Lanz1, EA. Bocchi1 


D 4 – 7 Differential diagnosis of electrocardiographic ST segment depressions 

C. Cihalik1, M. Taborsky2, E. Pospisilova1, P. Tuma1, J. Galuszka2 

1 Bata Hospital Zlin, Czech Republic 

2 University Hospital Olomouc, Czech Republic 

31

Printed in Austria by: 

ROBIDRUCK, 1200 Vienna – www.robidruck.co.at 

32

Sponsors (per July 2010) 

AMACORD 

ABBOTT VASCULAR 

ASTRAZENECA 

BIOMEDICA 

BIOSENSE/ZODL 

BIOTRONIK 

BOEHRINGER INGELHEIM 

BRAHMS 

CORDIS/JOHNSON&JOHNSON 

EKOMED 

ELI LILLY/DAIICHI SANKYO 

MERCK 

PFIZER 

ROCHE DIAGNOSTICS 

sanofi-aventis 

St. JUDE 

THE MEDICINE COMPANY

alpe adria association of cardiology

Create successful ePaper yourself

Delete template?

Save as template?